<h3>Gainers</h3>
<ul>
<li>Apellis Pharmaceuticals (NASDAQ:APLS) shares increased by 135.5% to $40.26 during Tuesday's regular session. The company's market cap stands at $2.1 billion. </li>
<li>Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 62.85% to $1.71. The company's market cap stands at $13.2 million. </li>
<li>Centessa Pharmaceuticals (NASDAQ:CNTA) stock rose 44.76% to $39.92. The company's market cap stands at $4.0 billion. </li>
<li>Virax Biolabs Group (NASDAQ:VRAX) stock increased by 29.84% to $0.21. The company's market cap stands at $1.2 million. </li>
<li>Cypherpunk Technologies (NASDAQ:CYPH) shares moved upwards by 25.35% to $0.78. The company's market cap stands at $56.2 million. </li>
<li>Insight Molecular (NASDAQ:IMDX) shares rose 24.7% to $3.18. The company's market cap stands at $82.0 million. As per the press release, Q4 earnings came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>IO Biotech (NASDAQ:IOBT) stock declined by 73.2% to $0.05 during Tuesday's regular session. The market value of their outstanding shares is at $12.4 million. </li>
<li>PepGen (NASDAQ:PEPG) shares decreased by 63.72% to $1.53. The market value of their outstanding shares is at $290.8 million. </li>
<li>Iterum Therapeutics (NASDAQ:ITRM) stock fell 45.74% to $0.04. The company's market cap stands at $3.7 million. </li>
<li>Phreesia (NYSE:PHR) shares declined by 29.41% to $8.05. The market value of their outstanding shares is at $687.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Sangamo Therapeutics (NASDAQ:SGMO) stock declined by 25.48% to $0.23. The company's market cap stands at $114.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Agape ATP (NASDAQ:ATPC) shares fell 20.82% to $2.59. The market value of their outstanding shares is at $3.2 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRAX

In Tuesday's intraday session, Apellis Pharmaceuticals saw a significant gain of 135.5%, reaching $40.26, with a market cap of $2.1 billion. Other notable gainers included Bullfrog AI Hldgs (+62.85%), Centessa Pharmaceuticals (+44.76%), and Virax Biolabs Group (+29.84%). Conversely, IO Biotech experienced a sharp decline of 73.2%, dropping to $0.05, followed by PepGen (-63.72%) and Iterum Therapeutics (-45.74%). The Q4 earnings reports influenced these movements, with several companies reporting significant changes in stock prices.

benzinga_article

VanEck Biotech ETF

Virax Biolabs

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

Bullfrog AI

iShares Biotechnology ETF

PepGen

Iterum Therap

BULLFROG AI HOLDINGS INC C/WTS EXP (TO PUR COM)

Direxion S&P Biotech Bull 3X

SPDR S&P Biotech

Centessa Pharmaceuticals

Proshares Ultra Nasdaq Biotech

Health Care Select Sector SPDR

ALPS Medical Breakthrough

IO Biotech

Invesco Nasdaq Biotechnology ETF

Apellis Pharma

iShares Global Healthcare

Ark Genomic Revolution ETF

VG Health

ITERUM THERAPEUTICS PLC

12 Health Care Stocks Moving In Tuesday's Intraday Session